374 reports of this reaction
3.0% of all LORATADINE AND PSEUDOEPHEDRINE SULFATE reports
#5 most reported adverse reaction
DIZZINESS is the #5 most commonly reported adverse reaction for LORATADINE AND PSEUDOEPHEDRINE SULFATE, manufactured by Bayer HealthCare LLC.. There are 374 FDA adverse event reports linking LORATADINE AND PSEUDOEPHEDRINE SULFATE to DIZZINESS. This represents approximately 3.0% of all 12,600 adverse event reports for this drug.
Patients taking LORATADINE AND PSEUDOEPHEDRINE SULFATE who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for LORATADINE AND PSEUDOEPHEDRINE SULFATE, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for LORATADINE AND PSEUDOEPHEDRINE SULFATE:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 374 FDA reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 3.0% of all adverse event reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE, making it a notable side effect.
If you experience dizziness while taking LORATADINE AND PSEUDOEPHEDRINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.